Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer.
Saved in:
| Title: | Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer. |
|---|---|
| Authors: | Petrova MP; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Donev IS; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Radanova MA; Department of Biochemistry and Molecular Medicine, Medical University of Varna, Varna, Bulgaria., Eneva MI; Hospital Pharmacy 'Nadezhda', Sofia, Bulgaria., Dimitrova EG; Clinic of Medical Oncology, UMHAT 'St Marina', Varna, Bulgaria., Valchev GN; Radiology Department, UMHAT 'St Marina', Varna, Bulgaria., Minchev VT; Department of Medical Oncology, University Hospital Sofiamed, Sofia, Bulgaria., Taushanova MS; Department of Medical Oncology, University Hospital Sofiamed, Sofia, Bulgaria., Boneva MV; Radiology Department, University Hospital Sofiamed, Sofia, Bulgaria., Karanikolova TS; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Gencheva RB; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Zhbantov GA; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Ivanova AI; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., Timcheva CV; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria., P Pavlov B; Radiology Department, MHAT 'Nadezhda', Sofia, Bulgaria., Megdanova VG; Deparment of Medical Oncology, UMHAT 'St Giovanna', Sofia, Bulgaria., Robev BS; Oncology Unit, University Hospital 'St Ivan Rilski', Sofia, Bulgaria., Conev NV; Clinic of Medical Oncology, UMHAT 'St Marina', Varna, Bulgaria. |
| Source: | Clinical and experimental immunology [Clin Exp Immunol] 2020 Dec; Vol. 202 (3), pp. 353-362. Date of Electronic Publication: 2020 Aug 26. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32757277 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Petrova+MP%22">Petrova MP</searchLink>; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Donev+IS%22">Donev IS</searchLink>; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Radanova+MA%22">Radanova MA</searchLink>; Department of Biochemistry and Molecular Medicine, Medical University of Varna, Varna, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Eneva+MI%22">Eneva MI</searchLink>; Hospital Pharmacy 'Nadezhda', Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Dimitrova+EG%22">Dimitrova EG</searchLink>; Clinic of Medical Oncology, UMHAT 'St Marina', Varna, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Valchev+GN%22">Valchev GN</searchLink>; Radiology Department, UMHAT 'St Marina', Varna, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Minchev+VT%22">Minchev VT</searchLink>; Department of Medical Oncology, University Hospital Sofiamed, Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Taushanova+MS%22">Taushanova MS</searchLink>; Department of Medical Oncology, University Hospital Sofiamed, Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Boneva+MV%22">Boneva MV</searchLink>; Radiology Department, University Hospital Sofiamed, Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Karanikolova+TS%22">Karanikolova TS</searchLink>; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Gencheva+RB%22">Gencheva RB</searchLink>; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Zhbantov+GA%22">Zhbantov GA</searchLink>; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Ivanova+AI%22">Ivanova AI</searchLink>; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Timcheva+CV%22">Timcheva CV</searchLink>; Clinic of Medical Oncology, MHAT 'Nadezhda', Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22P+Pavlov+B%22">P Pavlov B</searchLink>; Radiology Department, MHAT 'Nadezhda', Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Megdanova+VG%22">Megdanova VG</searchLink>; Deparment of Medical Oncology, UMHAT 'St Giovanna', Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Robev+BS%22">Robev BS</searchLink>; Oncology Unit, University Hospital 'St Ivan Rilski', Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Conev+NV%22">Conev NV</searchLink>; Clinic of Medical Oncology, UMHAT 'St Marina', Varna, Bulgaria. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220057202%22">Clinical and experimental immunology</searchLink> [Clin Exp Immunol] 2020 Dec; Vol. 202 (3), pp. 353-362. <i>Date of Electronic Publication: </i>2020 Aug 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0057202 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099104%22">00099104 </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32757277 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/cei.13505 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 353 Titles: – TitleFull: Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Petrova MP – PersonEntity: Name: NameFull: Donev IS – PersonEntity: Name: NameFull: Radanova MA – PersonEntity: Name: NameFull: Eneva MI – PersonEntity: Name: NameFull: Dimitrova EG – PersonEntity: Name: NameFull: Valchev GN – PersonEntity: Name: NameFull: Minchev VT – PersonEntity: Name: NameFull: Taushanova MS – PersonEntity: Name: NameFull: Boneva MV – PersonEntity: Name: NameFull: Karanikolova TS – PersonEntity: Name: NameFull: Gencheva RB – PersonEntity: Name: NameFull: Zhbantov GA – PersonEntity: Name: NameFull: Ivanova AI – PersonEntity: Name: NameFull: Timcheva CV – PersonEntity: Name: NameFull: P Pavlov B – PersonEntity: Name: NameFull: Megdanova VG – PersonEntity: Name: NameFull: Robev BS – PersonEntity: Name: NameFull: Conev NV IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2020 Dec Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1365-2249 Numbering: – Type: volume Value: 202 – Type: issue Value: 3 Titles: – TitleFull: Clinical and experimental immunology Type: main |
| ResultId | 1 |